Scholarlink

Median arcuate ligament syndrome (MALS) was first described in the early twentieth century (Metz et al. Eur J Vasc Endovasc Surg 64:720–732, 2022; Skelly and Mak. Semin Pediatr Surg 30:151129, 2021). Since this time, there has been much controversy and multiple theories on pathogenesis, diagnosis, and treatment (Metz et al. Eur J Vasc Endovasc Surg 64:720–732, 2022; Skelly and Mak. Semin Pediatr Surg 30:151129, 2021). While this condition remains rare, making substantial clinical trials difficult, since the 2000s there have been a number of studies and evidence-based literature supporting positive outcomes for the surgical treatment of MALS, specifically in the pediatric population. In this chapter, we aim to discuss the background, pathogenesis, diagnosis, and treatment of MALS for the pediatric population.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Median Arcuate Ligament Syndrome in the Pediatric Population

  • 章节

  • 发表日期：

    2025年

查看全文
  • Krysta M. Sutyak,
  • Imad Absah,
  • Abdalla E. Zarroug

摘要

Median arcuate ligament syndrome (MALS) was first described in the early twentieth century (Metz et al. Eur J Vasc Endovasc Surg 64:720–732, 2022; Skelly and Mak. Semin Pediatr Surg 30:151129, 2021). Since this time, there has been much controversy and multiple theories on pathogenesis, diagnosis, and treatment (Metz et al. Eur J Vasc Endovasc Surg 64:720–732, 2022; Skelly and Mak. Semin Pediatr Surg 30:151129, 2021). While this condition remains rare, making substantial clinical trials difficult, since the 2000s there have been a number of studies and evidence-based literature supporting positive outcomes for the surgical treatment of MALS, specifically in the pediatric population. In this chapter, we aim to discuss the background, pathogenesis, diagnosis, and treatment of MALS for the pediatric population.